Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Clare Octavia Kneen is active.

Publication


Featured researches published by Clare Octavia Kneen.


Bioorganic & Medicinal Chemistry Letters | 2009

Oxadiazolone bioisosteres of pregabalin and gabapentin.

David Juergen Wustrow; Thomas Richard Belliotti; Thomas Capiris; Clare Octavia Kneen; Justin Stephen Bryans; Mark J. Field; Dic Williams; Ayman El-Kattan; Lisa Buchholz; Jack J. Kinsora; Susan M. Lotarski; Mark G. Vartanian; Charles P. Taylor; Sean Donevan; Andrew John Thorpe; Jacob Bradley Schwarz

A series of oxadiazolone bioisosteres of pregabalin 1 and gabapentin 2 were prepared, and several were found to exhibit similar potency for the alpha(2)-delta subunit of voltage-gated calcium channels. Oxadiazolone 9 derived from 2 achieved low brain uptake but was nevertheless active in models of osteoarthritis. The high clearance associated with compound 9 was postulated to be a consequence of efflux by OAT and/or OCT, and was attenuated on co-administration with cimetidine or probenecid.


Journal of Medicinal Chemistry | 1990

Novel quinuclidine-based ligands for the muscarinic cholinergic receptor

John Saunders; Mark Cassidy; Stephen B. Freedman; Elizabeth A. Harley; Leslie L. Iversen; Clare Octavia Kneen; Angus Murray Macleod; Kevin John Merchant; Roger J. Snow; Raymond Baker


Journal of Medicinal Chemistry | 1998

Identification of Novel Ligands for the Gabapentin Binding Site on the α2δ Subunit of a Calcium Channel and Their Evaluation as Anticonvulsant Agents

Justin Stephen Bryans; Natasha Davies; Nicolas S. Gee; Visaka Udeni Karalliadde Dissanayake; Giles S. Ratcliffe; David Christopher Horwell; Clare Octavia Kneen; Andrew Morrell; Ryszard J. Oles; John O'Toole; Gemma M. Perkins; Lakhbir Singh; Nirmala Suman-Chauhan; Jacqueline A. O'Neill


Archive | 1998

1-substituted-1-aminomethyl-cycloalkane derivatives (= gabapentin analogues), their preparation and their use in the treatment of neurological disorders

Justin Stephen Bryans; Thomas Capiris; David Christopher Horwell; Clare Octavia Kneen; David Juergen Wustrow


Archive | 1997

Substituted gamma aminobutyric acids as pharmaceutical agents

Justin Stephen Bryans; David Christopher Horwell; Clare Octavia Kneen; David Juergen Wustrow; Andrew John Thorpe


Archive | 2000

Cyclic amino acids as pharmaceutical agents

David Christopher Horwell; Justin Stephen Bryans; Clare Octavia Kneen; Giles S. Ratcliffe


Archive | 1997

Novel substituted cyclic amino acids as pharmaceutical agents

David Christopher Horwell; Justin Stephen Bryans; Clare Octavia Kneen; Andrew Morrell; Giles S. Ratcliffe; Johannes Hartenstein


Archive | 1997

Bridged cyclic amino acids as pharmaceutical agents

David Christopher Horwell; Justin Stephen Bryans; Clare Octavia Kneen; Andrew Morrell; Giles S. Ratcliffe


Archive | 1998

Novel amines as pharmaceutical agents

Thomas Richard Belliotti; Justin Stephen Bryans; Thomas Capiris; David Christopher Horwell; Clare Octavia Kneen; David Juergen Wustrow


Archive | 1997

Substituted cyclic amino acids as pharmaceutical agents

David Christopher Horwell; Justin Stephen Bryans; Clare Octavia Kneen; Andrew Morrell; Giles S. Ratcliffe; Johannes Hartenstein

Collaboration


Dive into the Clare Octavia Kneen's collaboration.

Researchain Logo
Decentralizing Knowledge